scispace - formally typeset
J

James R. Feramisco

Researcher at University of California, San Diego

Publications -  126
Citations -  16751

James R. Feramisco is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Phosphorylation & Signal transduction. The author has an hindex of 65, co-authored 126 publications receiving 16438 citations. Previous affiliations of James R. Feramisco include National Institutes of Health & Cold Spring Harbor Laboratory.

Papers
More filters
Journal ArticleDOI

Activation of cAMP and mitogen responsive genes relies on a common nuclear factor

TL;DR: It is reported here that micro-injection of an anti-CBP antiserum into fibroblasts can inhibit transcription from a cAMP responsive promoter, and proposed that CBP is recruited to the promoter through interaction with certain phosphorylated factors, and may thus play a critical role in the transmission of inductive signals from cell surface receptor to the transcriptional apparatus.
Journal ArticleDOI

Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation

TL;DR: Microinjection of the proto-oncogenic and oncogenic forms of the human H-ras protein into living rat pheochromocytoma cells promoted the morphological differentiation of PC12 cells into neuron-like cells.
Journal ArticleDOI

Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins

TL;DR: The stimulatory effect of the ras oncogene protein on ruffling and pinocytosis is dependent on the amount of injected protein and is accompanied by an apparent stimulation of phospholipase A2 activity, which may represent primary events in the mechanism of action of ras proteins.
Journal ArticleDOI

DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps.

TL;DR: A significant role for NETs in neutrophil-mediated innate immunity is demonstrated, and a novel therapeutic target against invasive GAS infection is identified.
Journal ArticleDOI

Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

TL;DR: Heparin treatment attenuates tumor metastasis in mice by inhibiting P-selectin-mediated interactions of platelets with carcinoma cell-surface mucin ligands, and it is suggested that heparin therapy for metastasis prevention in humans be revisited, with these mechanistic paradigms in mind.